| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |